Clinical Notes: Fusion Drug Staves Off Cancer Progression
(MedPage Today) — Using trastuzumab to deliver a chemotherapy agent directly to cancer cells appeared to work in a phase III clinical trial. Also this week: failure for mesalamine in diverticulitis and delay for a new COPD drug.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com